Mechanically Optimizing Cardiac Preload in Heart Failure Patients

March 28, 2023 updated by: Cardioflow Technologies, LLC

Mechanically Optimizing Cardiac Preload Using Partial Inferior Vena Cava Occlusion to Reduce Pulmonary Pressures in Heart Failure Patients in Heart Failure Patients

The purpose of the current study is to determine if partial balloon occlusion of the inferior vena cava can optimize cardiac pre-load and subsequently pulmonary pressures and cardiac output as a novel method to unload pulmonary edema and other symptoms of decompensated congestive heart failure. All products in this study are FDA approved and adhere to the specifications of the intended use.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Anticipated)

10

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Tennessee
      • Nashville, Tennessee, United States, 37205
        • Recruiting
        • Saint Thomas Heart

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Decompensated congestive heart failure patients referred for right heart catheterization.

Description

Inclusion Criteria:

  1. Subjects scheduled to undergo a right heart catheterization at Saint Thomas Hospital.
  2. New York Heart Association (NYHA) II or III.
  3. Subjects must be last least 18 years of age.
  4. A left ventricular ejection fraction >= 20%.
  5. Pulmonary artery occlusion pressure, or pulmonary wedge pressure >20 mmHg.

Exclusion Criteria:

  1. Subjects without sinus rhythm.
  2. Evidence of right heart failure.
  3. Patients with primary pulmonary hypertension
  4. Pulmonary wedge pressure <15mmHg.
  5. Significant lung disease, such as prior diagnosis of COPD.
  6. Resting or dynamic outflow tract gradient
  7. Patients with left bundle branch block

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
HF patients
Decompensated heart failure patients undergoing right heart catheterization.
Partial balloon occlusion of the inferior vena cava.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in pulmonary arterial pressures
Time Frame: During partial balloon occlusion
Change in the measured mean pulmonary arterial pressure
During partial balloon occlusion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in cardiac output
Time Frame: During partial balloon occlusion
Change in cardiac output measured in liters per minute
During partial balloon occlusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2021

Primary Completion (Anticipated)

June 30, 2024

Study Completion (Anticipated)

June 30, 2024

Study Registration Dates

First Submitted

April 5, 2020

First Submitted That Met QC Criteria

April 5, 2020

First Posted (Actual)

April 8, 2020

Study Record Updates

Last Update Posted (Actual)

March 30, 2023

Last Update Submitted That Met QC Criteria

March 28, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CFT-37215-STH-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Failure

Clinical Trials on Partial IVC occlusion

3
Subscribe